{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T04:13:54Z","timestamp":1746591234221,"version":"3.40.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260043"],"award-info":[{"award-number":["82260043"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20232ACB206016, 20204BCJ22030"],"award-info":[{"award-number":["20232ACB206016, 20204BCJ22030"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012259","name":"Major Discipline Academic and Technical Leaders Training Program of Jiangxi Province","doi-asserted-by":"publisher","award":["20225BCJ22001"],"award-info":[{"award-number":["20225BCJ22001"]}],"id":[{"id":"10.13039\/501100012259","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02517-z","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T06:49:00Z","timestamp":1746514140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Global trends and research status in clonal hematopoiesis: a bibliometric analysis of the last 10\u00a0years"],"prefix":"10.1007","volume":"16","author":[{"given":"QingQing","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"issue":"26","key":"2517_CR1","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","volume":"371","author":"G Genovese","year":"2014","unstructured":"Genovese G, K\u00e4hler AK, Handsaker RE, Lindberg J, Rose SA, Bakhoum SF, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014;371(26):2477\u201387. https:\/\/doi.org\/10.1056\/NEJMoa1409405.","journal-title":"N Engl J Med"},{"issue":"26","key":"2517_CR2","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman PV, Mar BG, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371(26):2488\u201398. https:\/\/doi.org\/10.1056\/NEJMoa1408617.","journal-title":"N Engl J Med"},{"issue":"7831","key":"2517_CR3","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41586-020-2819-2","volume":"586","author":"AG Bick","year":"2020","unstructured":"Bick AG, Weinstock JS, Nandakumar SK, Fulco CP, Bao EL, Zekavat SM, et al. Inherited causes of clonal haematopoiesis in 97,691 whole genomes. Nature. 2020;586(7831):763\u20138. https:\/\/doi.org\/10.1038\/s41586-020-2819-2.","journal-title":"Nature"},{"issue":"18","key":"2517_CR4","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1182\/blood.2022018825","volume":"141","author":"C Vlasschaert","year":"2023","unstructured":"Vlasschaert C, Mack T, Heimlich JB, Niroula A, Uddin MM, Weinstock J, et al. A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic data sets. Blood. 2023;141(18):2214\u201323. https:\/\/doi.org\/10.1182\/blood.2022018825.","journal-title":"Blood"},{"key":"2517_CR5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI180065","author":"WG Dunn","year":"2024","unstructured":"Dunn WG, McLoughlin MA, Vassiliou GS. Clonal hematopoiesis and hematological malignancy. J Clin Invest. 2024. https:\/\/doi.org\/10.1172\/JCI180065.","journal-title":"J Clin Invest"},{"key":"2517_CR6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI180066","author":"O Oren","year":"2024","unstructured":"Oren O, Small AM, Libby P. Clonal hematopoiesis and atherosclerosis. J Clin Invest. 2024. https:\/\/doi.org\/10.1172\/JCI180066.","journal-title":"J Clin Invest"},{"issue":"14","key":"2517_CR7","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1182\/blood.2019000989","volume":"136","author":"S Jaiswal","year":"2020","unstructured":"Jaiswal S. Clonal hematopoiesis and nonhematologic disorders. Blood. 2020;136(14):1606\u201314. https:\/\/doi.org\/10.1182\/blood.2019000989.","journal-title":"Blood"},{"issue":"7958","key":"2517_CR8","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41586-023-05857-4","volume":"616","author":"WJ Wong","year":"2023","unstructured":"Wong WJ, Emdin C, Bick AG, Zekavat SM, Niroula A, Pirruccello JP, et al. Clonal haematopoiesis and risk of chronic liver disease. Nature. 2023;616(7958):747\u201354. https:\/\/doi.org\/10.1038\/s41586-023-05857-4.","journal-title":"Nature"},{"issue":"10","key":"2517_CR9","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1182\/blood.2022015384","volume":"140","author":"M Agrawal","year":"2022","unstructured":"Agrawal M, Niroula A, Cunin P, McConkey M, Shkolnik V, Kim PG, et al. TET2-mutant clonal hematopoiesis and risk of gout. Blood. 2022;140(10):1094\u2013103. https:\/\/doi.org\/10.1182\/blood.2022015384.","journal-title":"Blood"},{"issue":"8","key":"2517_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41408-018-0107-2","volume":"8","author":"P Savola","year":"2018","unstructured":"Savola P, Lundgren S, Ker\u00e4nen MAI, Almusa H, Ellonen P, Leirisalo-Repo M, et al. Clonal hematopoiesis in patients with rheumatoid arthritis. Blood Cancer J. 2018;8(8):69. https:\/\/doi.org\/10.1038\/s41408-018-0107-2.","journal-title":"Blood Cancer J"},{"issue":"4","key":"2517_CR11","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1111\/cas.15294","volume":"113","author":"X Liu","year":"2022","unstructured":"Liu X, Sato N, Shimosato Y, Wang TW, Denda T, Chang YH, et al. CHIP-associated mutant ASXL1 in blood cells promotes solid tumor progression. Cancer Sci. 2022;113(4):1182\u201394. https:\/\/doi.org\/10.1111\/cas.15294.","journal-title":"Cancer Sci"},{"issue":"6568","key":"2517_CR12","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1126\/science.aba9304","volume":"374","author":"S Avagyan","year":"2021","unstructured":"Avagyan S, Henninger JE, Mannherz WP, Mistry M, Yoon J, Yang S, et al. Resistance to inflammation underlies enhanced fitness in clonal hematopoiesis. Science. 2021;374(6568):768\u201372. https:\/\/doi.org\/10.1126\/science.aba9304.","journal-title":"Science"},{"issue":"3","key":"2517_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s40037-021-00695-4","volume":"11","author":"A Ninkov","year":"2022","unstructured":"Ninkov A, Frank JR, Maggio LA. Bibliometrics: methods for studying academic publishing. Perspect Med Educ. 2022;11(3):173\u20136. https:\/\/doi.org\/10.1007\/s40037-021-00695-4.","journal-title":"Perspect Med Educ"},{"key":"2517_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.686726","volume":"11","author":"J Zhang","year":"2021","unstructured":"Zhang J, Song L, Xu L, Fan Y, Wang T, Tian W, et al. Knowledge domain and emerging trends in ferroptosis research: a bibliometric and knowledge-map analysis. Front Oncol. 2021;11: 686726. https:\/\/doi.org\/10.3389\/fonc.2021.686726.","journal-title":"Front Oncol"},{"issue":"9","key":"2517_CR15","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1097\/JS9.0000000000000492","volume":"109","author":"S Jiang","year":"2023","unstructured":"Jiang S, Liu Y, Zheng H, Zhang L, Zhao H, Sang X, et al. Evolutionary patterns and research frontiers in neoadjuvant immunotherapy: a bibliometric analysis. Int J Surg. 2023;109(9):2774\u201383. https:\/\/doi.org\/10.1097\/JS9.0000000000000492.","journal-title":"Int J Surg"},{"key":"2517_CR16","doi-asserted-by":"publisher","first-page":"1147265","DOI":"10.3389\/fcimb.2023.1147265","volume":"13","author":"X Yuan","year":"2023","unstructured":"Yuan X, Lai Y. Bibliometric and visualized analysis of elite controllers based on CiteSpace: landscapes, hotspots, and frontiers. Front Cell Infect Microbiol. 2023;13:1147265. https:\/\/doi.org\/10.3389\/fcimb.2023.1147265.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"2517_CR17","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","volume":"84","author":"NJ van Eck","year":"2010","unstructured":"van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84(2):523\u201338.","journal-title":"Scientometrics"},{"issue":"6","key":"2517_CR18","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1182\/blood-2017-02-769869","volume":"130","author":"F Zink","year":"2017","unstructured":"Zink F, Stacey SN, Norddahl GL, Frigge ML, Magnusson OT, Jonsdottir I, et al. Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. Blood. 2017;130(6):742\u201352. https:\/\/doi.org\/10.1182\/blood-2017-02-769869.","journal-title":"Blood"},{"key":"2517_CR19","doi-asserted-by":"publisher","first-page":"12484","DOI":"10.1038\/ncomms12484","volume":"7","author":"AL Young","year":"2016","unstructured":"Young AL, Challen GA, Birmann BM, Druley TE. Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults. Nat Commun. 2016;7:12484. https:\/\/doi.org\/10.1038\/ncomms12484.","journal-title":"Nat Commun"},{"issue":"11","key":"2517_CR20","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-020-00710-0","volume":"52","author":"KL Bolton","year":"2020","unstructured":"Bolton KL, Ptashkin RN, Gao T, Braunstein L, Devlin SM, Kelly D, et al. Cancer therapy shapes the fitness landscape of clonal hematopoiesis. Nat Genet. 2020;52(11):1219\u201326. https:\/\/doi.org\/10.1038\/s41588-020-00710-0.","journal-title":"Nat Genet"},{"key":"2517_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2017.07.010","author":"CC Coombs","year":"2017","unstructured":"Coombs CC, Zehir A, Devlin SM, Kishtagari A, Syed A, Jonsson P, et al. Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes. Cell Stem Cell. 2017. https:\/\/doi.org\/10.1016\/j.stem.2017.07.010.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"2517_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","volume":"377","author":"S Jaiswal","year":"2017","unstructured":"Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E, et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med. 2017;377(2):111\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1701719.","journal-title":"N Engl J Med"},{"issue":"6327","key":"2517_CR23","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1126\/science.aag1381","volume":"355","author":"JJ Fuster","year":"2017","unstructured":"Fuster JJ, MacLauchlan S, Zuriaga MA, Polackal MN, Ostriker AC, Chakraborty R, et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science. 2017;355(6327):842\u20137. https:\/\/doi.org\/10.1126\/science.aag1381.","journal-title":"Science"},{"key":"2517_CR24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-631747","author":"DP Steensma","year":"2015","unstructured":"Steensma DP, Bejar R, Jaiswal S, Lindsley RC, Sekeres MA, Hasserjian RP, et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015. https:\/\/doi.org\/10.1182\/blood-2015-03-631747.","journal-title":"Blood"},{"issue":"12","key":"2517_CR25","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/nm.3733","volume":"20","author":"M Xie","year":"2014","unstructured":"Xie M, Lu C, Wang J, McLellan MD, Johnson KJ, Wendl MC, et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat Med. 2014;20(12):1472\u20138. https:\/\/doi.org\/10.1038\/nm.3733.","journal-title":"Nat Med"},{"issue":"7","key":"2517_CR26","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022;36(7):1703\u201319. https:\/\/doi.org\/10.1038\/s41375-022-01613-1.","journal-title":"Leukemia"},{"issue":"6","key":"2517_CR27","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/s41588-024-01755-1","volume":"56","author":"N Bernstein","year":"2024","unstructured":"Bernstein N, Spencer Chapman M, Nyamondo K, Chen Z, Williams N, Mitchell E, et al. Analysis of somatic mutations in whole blood from 200,618 individuals identifies pervasive positive selection and novel drivers of clonal hematopoiesis. Nat Genet. 2024;56(6):1147\u201355. https:\/\/doi.org\/10.1038\/s41588-024-01755-1.","journal-title":"Nat Genet"},{"issue":"26","key":"2517_CR28","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1182\/blood.2023022222","volume":"142","author":"LD Weeks","year":"2023","unstructured":"Weeks LD, Ebert BL. Causes and consequences of clonal hematopoiesis. Blood. 2023;142(26):2235\u201346. https:\/\/doi.org\/10.1182\/blood.2023022222.","journal-title":"Blood"},{"issue":"8","key":"2517_CR29","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jacc.2017.12.037","volume":"71","author":"S Sano","year":"2018","unstructured":"Sano S, Oshima K, Wang Y, MacLauchlan S, Katanasaka Y, Sano M, et al. Tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1\u03b2\/NLRP3 inflammasome. J Am Coll Cardiol. 2018;71(8):875\u201386. https:\/\/doi.org\/10.1016\/j.jacc.2017.12.037.","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"2517_CR30","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1161\/CIRCULATIONAHA.123.065597","volume":"149","author":"AE Lin","year":"2024","unstructured":"Lin AE, Bapat AC, Xiao L, Niroula A, Ye J, Wong WJ, et al. Clonal hematopoiesis of indeterminate potential with loss of Tet2 enhances risk for atrial fibrillation through Nlrp3 inflammasome activation. Circulation. 2024;149(18):1419\u201334. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.065597.","journal-title":"Circulation"},{"key":"2517_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.06.022","author":"I Cobo","year":"2022","unstructured":"Cobo I, Tanaka TN, Chandra Mangalhara K, Lana A, Yeang C, Han C, et al. DNA methyltransferase 3 alpha and TET methylcytosine dioxygenase 2 restrain mitochondrial DNA-mediated interferon signaling in macrophages. Immunity. 2022. https:\/\/doi.org\/10.1016\/j.immuni.2022.06.022.","journal-title":"Immunity"},{"issue":"3","key":"2517_CR32","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1161\/CIRCRESAHA.118.313225","volume":"123","author":"S Sano","year":"2018","unstructured":"Sano S, Oshima K, Wang Y, Katanasaka Y, Sano M, Walsh K. CRISPR-mediated gene editing to assess the roles of Tet2 and Dnmt3a in clonal hematopoiesis and cardiovascular disease. Circ Res. 2018;123(3):335\u201341. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313225.","journal-title":"Circ Res"},{"issue":"2","key":"2517_CR33","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1161\/CIRCRESAHA.120.317104","volume":"128","author":"WT Abplanalp","year":"2021","unstructured":"Abplanalp WT, Cremer S, John D, Hoffmann J, Schuhmacher B, Merten M, et al. Clonal hematopoiesis-driver DNMT3A mutations alter immune cells in heart failure. Circ Res. 2021;128(2):216\u201328. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.317104.","journal-title":"Circ Res"},{"key":"2517_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103964","volume":"78","author":"S Wang","year":"2022","unstructured":"Wang S, Hu S, Luo X, Bao X, Li J, Liu M, et al. Prevalence and prognostic significance of DNMT3A- and TET2- clonal haematopoiesis-driver mutations in patients presenting with ST-segment elevation myocardial infarction. EBioMedicine. 2022;78: 103964. https:\/\/doi.org\/10.1016\/j.ebiom.2022.103964.","journal-title":"EBioMedicine"},{"issue":"3","key":"2517_CR35","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1182\/blood.2021013531","volume":"139","author":"PG Miller","year":"2022","unstructured":"Miller PG, Qiao D, Rojas-Quintero J, Honigberg MC, Sperling AS, Gibson CJ, et al. Association of clonal hematopoiesis with chronic obstructive pulmonary disease. Blood. 2022;139(3):357\u201368. https:\/\/doi.org\/10.1182\/blood.2021013531.","journal-title":"Blood"},{"issue":"11","key":"2517_CR36","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.2337\/dc23-0805","volume":"46","author":"DK Tobias","year":"2023","unstructured":"Tobias DK, Manning AK, Wessel J, Raghavan S, Westerman KE, Bick AG, et al. Clonal hematopoiesis of indeterminate potential (CHIP) and incident type 2 diabetes risk. Diabetes Care. 2023;46(11):1978\u201385. https:\/\/doi.org\/10.2337\/dc23-0805.","journal-title":"Diabetes Care"},{"key":"2517_CR37","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211872","author":"PG Kim","year":"2021","unstructured":"Kim PG, Niroula A, Shkolnik V, McConkey M, Lin AE, S\u0142abicki M, et al. Dnmt3a-mutated clonal hematopoiesis promotes osteoporosis. J Exp Med. 2021. https:\/\/doi.org\/10.1084\/jem.20211872.","journal-title":"J Exp Med"},{"issue":"7","key":"2517_CR38","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1200\/JCO.22.00857","volume":"41","author":"R Tian","year":"2023","unstructured":"Tian R, Wiley B, Liu J, Zong X, Truong B, Zhao S, et al. Clonal hematopoiesis and risk of incident lung cancer. J Clin Oncol. 2023;41(7):1423\u201333. https:\/\/doi.org\/10.1200\/JCO.22.00857.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2517_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41467-020-20162-8","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Yao Y, Xu Y, Li L, Gong Y, Zhang K, et al. Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients. Nat Commun. 2021;12(1):11. https:\/\/doi.org\/10.1038\/s41467-020-20162-8.","journal-title":"Nat Commun"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02517-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02517-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02517-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T06:49:01Z","timestamp":1746514141000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02517-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2517"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02517-z","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,6]]},"assertion":[{"value":"24 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"671"}}